"piRNAsareexpressedinnormalmammalianbrainspecimens(28).TheobjectiveofthisstudywasthereforetoexaminewhetherinheritedvariantsinpiRNA-encodinglociareassoci-atedwithgliomariskusingdatafrom1,840gliomacasesand2,401controlsfromtheGliomaScanCohort(29)andtoexaminetheunderlyingbasisforoneoftheobservedassocia-tionsusinginvitrofunctionalstudies.MaterialsandMethodsStudysubjectsanddataIndividual-levelgenotypedataandphenotypicsubjectchar-acteristicsforparticipantsoftheGliomaScanCohortbasedGenome-wideAssociationStudy(29)weredownloadedfromtheDatabaseofGenotypesandPhenotypes(dbGaP,StudyAccessionphs000652.v1.p1)afterreceivingdataaccessautho-rization.SubjectswererestrictedtothosegenotypedontheIlluminaHuman660W-QuadBeadChiptoavoidpotentialbiasintroducedbythecasecontrolimbalanceofsubjectsgeno-typedonotherplatforms.Afterremovalofrelatedorduplicatesubjects(n25cases,n150controls),therewere1,840cases(ICDO-3codes9380-9480)and2,401controlsincludedfornalanalysis.IdenticationofpiRNAvariantsGenomiccoordinatesforallexperimentallyobservedhumanpiRNAswereobtainedfromthepiRNABankdatabase(30).SNPsincludedinthe1,000GenomesProjectPhase3(31)referencevariantset(n77,818,332biallelicSNPs)wereidentiedwithinthesecoordinates.SNPsinpiRNAsthatmaptomorethan1,00genomiclociwereexcluded,asthesepiRNAsmaybelesslikelytobeinvolvedinprotein-codinggeneregulation(8).piRNAvariantgenotypeimputationGenotypeandphenotypedataweredownloadedtoasecureserveratYaleUniversityanddecryptedandextractedaccordingtodbGaPguidelines.1,000GenomesPhaseIIIhaplotypesweredownloadedforuseasthereferencepanelforimputationusingIMPUTEv2.3.1software(32).InputdatawererestrictedtoSNPswithcallrate90%andHardyWeinbergequilib-riumHWEP>0.0001usingthePLINKtoolset(33).FinemappingwasconductedviaimputationofallSNPswithminorallelicfrequency(MAF)>1%in5-Mbchunks,andregionalannotationswerederivedfromtheUCSCGenomeBrowser(34).StatisticalanalysisforassociationstudyORsand95%condenceintervals(CI)forvariant-gliomaassociationswereestimatedwithSNPTESTv2.5software(35),applyinganadditivealleliclogisticregressionmodeladjustingforsex,age,studydesign,andthersttwoprincipalcomponents.PrincipalcomponentsweregeneratedbythesmartPCAalgorithmintheEIGENSOFTv6.0populationgeneticspackagetoadjustforresidualpopulationsubstructure(36).Associationssurpas-singaBonferroni-correctedsignicancethresholdweredeemedstatisticallysignicantandassociationsyieldingfalsediscoveryrate-adjustedP<0.10wereconsideredtobemodestassociationsofinterest(37).ExperimentalcelllinesandreagentsGliomacelllinesU87andA172werepurchasedfromATCCandimmortalizednormalhumanastrocytes(NHA)werepur-chasedfromtheUniversityofCalifornia,SanFranciscoTissueCore.Allcelllinesaretestedforcontaminantsandauthenticatedpriortoshipmentusingseveralcharacterizationapproachesincludingmorphologyassessment,karyotyping,cytochromecoxidasevariantanalysis,andshorttandemrepeatDNAnger-printing.Cellswerenotreauthenticatedastheywerepassagedinourlaboratoryforfewerthan6monthsafterresuscitation.CellsweremaintainedinEagle'smodiedessentialmedium(U87)orMEM(A172,NHA)andsupplementedwith10%FBS.Single-strandedpiRNAmimicswerepurchasedfromIDT(Sup-plementaryTableS1),andsingle-strandednontargetingRNAsequencesofsimilarsizewerepurchasedfromQIAGENtoactasnegativecontrolsininvitroexperiments.Cellswerereverse-transfectedusingLipofectAMINERNAiMAXtransfectionreagent(Invitrogen)accordingtothemanufacturer'sinstructions.MeasurementofpiRNAexpressionTotalRNAwasisolatedfromU87,A172,andNHAcelllysatesusingthemiRNeasyMiniKit(QIAGEN),andcDNAwasgeneratedusingtheNCodemiRNAFirstStrandcDNASynthesisKit(Invi-trogen).qPCRwasperformedonanABI-7500System(AppliedBiosystems)usingaSYBRFASTqPCRKit(KapaBiosystems).AmplicationreactionswereconductedintriplicatewithcustomshortpiRNAforwardprimersandauniversalreverseprimertargetingappendedpoly(A)tails(SupplementaryTableS1).ExpressionlevelswerenormalizedtosmallnuclearRNAU6expression.PredictedsecondarystructuresofpiRNAsweregen-eratedbytheMfoldv3.6RNAfoldingalgorithmusingdefaultparameters(38).Genome-wideexpressionprolingU87cellswerereversetransfectedwitheitherwild-typepiR-598oranontargetcontrol(NC)RNA.Cellswereharvested24hoursaftertransfection,andtotalRNAwasisolatedandapprox-imately1mgwassubmittedtotheYaleCenterforGenomeAnalysisforgenome-wideexpressionprolingontheIlluminaHumanHT-12v4ExpressionBeadChipplatforminbiologicduplicate.GenesshowingexpressionleveldifferencesbetweenNC-andpiR-598-WTtreatmentsbeyondasignicancethresh-oldoffalsediscoveryrate(FDR)-adjustedP0.05wereconsideredtobedifferentiallyexpressed.Fivegeneswereselect-edforexpressionvalidationbyqPCRwithinputnormalizationtoGAPDH.NetworkandpathwayanalyseswereconductedusingIngenuityPathwayAnalysis(IPA)software;PvaluesforaffectedfunctionalpathwayswerecalculatedusingaFisherexacttestforenrichmentofaffectedgeneswithaparticularfunctionalannotation.ArraydatahavebeendepositedintheNCBIGeneExpressionOmnibusrepository(accessionnumberGSE78935).CellviabilityassayCellviabilitywasevaluatedinpiRNA-598-andnegativecontrolRNA-treatedcellpopulationsusingtheCellTiter96AQueousOneSolutionCellProliferationAssay(MTS)Kit(Promega).Briey,cellviabilitywasquantiedat48and96hoursaftertransfection.Colordevelopmentwasevaluated1hourafteradditionofMTSusingamicroplatespectrophotometeratanabsorbanceofJacobsetal.CancerEpidemiolBiomarkersPrev;25(7)July2016CancerEpidemiology,Biomarkers&PreventionOF2Research. on February 6, 2020.  2016 American Association for Cancercebp.aacrjournals.org Downloaded from Published OnlineFirst May 13, 2016; DOI: 10.1158/1055-9965.EPI-16-0047 "